Direct convective delivery of macromolecules to the spinal cord
- 1 October 1998
- journal article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 89 (4), 616-622
- https://doi.org/10.3171/jns.1998.89.4.0616
Abstract
Object. Because of the limited penetration of macromolecules across the blood—spinal cord barrier, numerous therapeutic compounds with potential for treating spinal cord disorders cannot be used effectively. The authors have developed a technique to deliver and distribute macromolecules regionally in the spinal cord by using convection in the interstitial space. Methods. The authors designed a delivery system connected to a “floating” silica cannula (inner diameter 100 µm, outer diameter 170 µm) that provides for constant volumetric inflow to the spinal cord. A solution containing albumin that was either unlabeled or labeled with carbon-14 or gadolinium was infused at various volumes (3, 6, 10, 20, 40, or 50 µl) at a rate of 0.1 µl/minute into the spinal cord dorsal columns of nine swine and into the lateral columns of three primates (Macaca mulatta). Volume of distribution (Vd), concentration homogeneity, and percentage of recovery were determined using scintillation analysis, kurtosis calculation (K), and quantitative autoradiography (six swine), magnetic resonance imaging (one swine and three primates), and histological analysis (all animals). Neurological function was observed for up to 3 days in four of the swine and up to 16 weeks in the three primates. The Vd of 14C-albumin was linearly proportional (R2 = 0.97) to the volume of infusion (Vi) (Vd/Vi = 4.4 ± 0.5; [mean ± standard deviation]). The increases in Vd resulting from increases in Vi were primarily in the longitudinal dimension (R2 = 0.83 in swine; R2 = 0.98 in primates), allowing large segments of spinal cord (up to 4.3 cm; Vi 50 µl) to be perfused with the macromolecule. The concentration across the area of distribution was homogeneous (K = −1.1). The mean recovery of infused albumin from the spinal cord was 85.5 ± 5.6%. Magnetic resonance imaging and histological analysis combined with quantitative autoradiography revealed the albumin infusate to be preferentially distributed along the white matter tracts. No animal exhibited a neurological deficit as a result of the infusion. Conclusions. Regional convective delivery provides reproducible, safe, region-specific, and homogeneous distribution of macromolecules over large longitudinal segments of the spinal cord. This delivery method overcomes many of the obstacles associated with current delivery techniques and provides for research into new treatments of various conditions of the spinal cord.Keywords
This publication has 11 references indexed in Scilit:
- Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with singlephoton emission computerized tomography imagingJournal of Neurosurgery, 1997
- Pharmacokinetics of Intrathecally Applied BDNF and Effects on Spinal MotoneuronsExperimental Neurology, 1996
- Microstructural and Physiological Features of Tissues Elucidated by Quantitative-Diffusion-Tensor MRIJournal of Magnetic Resonance, Series B, 1996
- A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosisAnnals of Neurology, 1996
- Brain drug delivery and blood–brain barrier transportDrug Delivery, 1996
- Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusionJournal of Neurosurgery, 1995
- Convection-enhanced delivery of macromolecules in the brain.Proceedings of the National Academy of Sciences, 1994
- Ciliary neurotrophic factor: Pharmacokinetics and acute‐phase response in ratAnnals of Neurology, 1994
- Albumin Labeled with Gd-DTPAInvestigative Radiology, 1987
- Role of pressure gradients and bulk flow in dynamics of vasogenic brain edemaJournal of Neurosurgery, 1977